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http://dx.doi.org/10.1016/j.jmii.2013Background: Klebsiella pneumoniae liver abscess (KPLA) has emerged as an endemic disease in
Taiwan, and its prevalence has been increasing in east Asian countries in the past three de-
cades. The utilization of healthcare resources associated with KPLA is assumed to be substan-
tial, and may be of future concern. This study investigated the clinical characteristics and
economic burden of KPLA in Taiwan in 2011 and 2012.
Methods: Adult patients with KPLA were identified retrospectively in a tertiary medical center
in Taiwan from January 2011 to December 2012. The clinical characteristics, total and daily
hospitalization expenditure, and the risk factors for the costs of KPLA were analyzed.
Results: Among patients with KPLA, the median cost was $5290.80 in US dollars, and the mean
cost was $6337.50  $4363.40. Length of hospital stay was the only independent risk factor for
the high total hospitalization expenditure. The duration of antibiotic use was nearly the same
as the length of hospital stay. The prolonged stay in the general ward (21 days) also contrib-
uted to the high total cost of hospitalization. The independent risk factors for the high average
daily cost of hospitalization were a higher Charlson Comorbidity Index and the requirement of
intensive care on admission.
Conclusion: The current study is the first to demonstrate the high economic burden resulting
from KPLA in a medical center in Taiwan. Standardizing the treatment protocol for KPLAfectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Number 201, Section 2,
City 11217, Taiwan.
.tw (Y.-T. Lin).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
.08.014
Economic consequence of K. pneumoniae liver abscess 191inpatients and introducing an outpatient parenteral antimicrobial therapy center to reduce the
length of stay may reduce costs, whereas development of a vaccine may be necessary to tackle
endemic KPLA in the future.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Pyogenic liver abscess is a common disease in Taiwan,1 and
the annual incidence of 11.99e17.59 per 100,000 popula-
tion2 is substantially higher than in Western countries, such
as Denmark,3 Canada,4 and the United States5 with annual
incidences of 1.0, 2.3, and 2.7e4.1 per 100,000 population,
respectively. In the past three decades, Klebsiella pneu-
moniae has emerged as the main cause of pyogenic liver
abscess in Taiwan and other East Asian countries, especially
Korea and Singapore,2,6e15 whereas Streptococcus species
and Escherichia coli are the predominant cause of pyogenic
liver abscess in Western countries.4,5 The increasing prev-
alence of K. pneumoniae liver abscess (KPLA), and the
associated distinctive invasive syndrome complicated by
endophthalmitis, central nervous system infection, and
septic metastatic lesions in other organs have contributed
to the endemic features of the disease in
Taiwan.1,2,6e9,11,12,16e21
The clinical and microbiological characteristics of KPLA
in Taiwan have been widely studied in the past three dec-
ades.2,6,7,9,11e14,18e26 The mortality rate of KPLA seemed to
be decreasing in recent years in Taiwan because of
increased physician awareness.2,22 However, concerns
remain over the metastatic complications of
KPLA,9,12,17e20,22 the long hospital stay,2,6,9,13,14 and the
associated illness requiring critical care.24 In addition,
some patients experience major disability and poor long-
term prognosis because of ocular or neurological compli-
cations arising from KPLA.17 As a result of the endemic
features of KPLA in Taiwan, the associated utilization of
healthcare resources is assumed to be substantial, but the
economic burden of KPLA in Taiwan has never been
determined.
In the current study, we aimed to investigate the clinical
characteristics of KPLA and the associated economic
consequence in a medical center in northern Taiwan in 2011
and 2012.
Methods
Study population
This retrospective cohort analysis was conducted at a 2900-
bed tertiary medical center, Taipei Veterans General Hos-
pital, from January 2011 to December 2012. In patients
enrolled in this study, the diagnosis of KPLA was made by
the presence of liver abscesses on abdominal ultrasonog-
raphy or computed tomography, plus identification of the
infectious organism isolated from liver pus or blood as
K. pneumoniae. Patients younger than 20 years were
excluded from the study. The study was approved by theInstitution Review Board of Taipei Veterans General
Hospital.
Data collection
Patient medical records were reviewed by clinicians, and
microbiological results of the liver abscess or blood were
acquired from the Department of Microbiology in our
hospital. Data on age, sex, underlying diseases, Charlson
Comorbidity Index, clinical presentations, laboratory
findings, Acute Physiology and Chronic Health Evaluation
(APACHE) II scores within 48 hours after admission, origin
and nature of the liver abscesses, radiological images, and
patient management were collected. The unavailable pa-
rameters of APACHE II score were considered as within
normal limits if there was no strong indication to measure
within 48 hours after admission. The outcome measure-
ments were: the requirement of intensive care on admis-
sion; the length of hospitalization; total expenditure
related to KPLA, including emergency department costs;
average daily hospital expenditure; and in-hospital mor-
tality. A liver abscess of cryptogenic origin was defined as
one in which no obvious extrahepatic source of infection
could be identified and there was no underlying hep-
atobiliary disease.21 A liver abscess of biliary tract origin
was defined when clinical features of cholecystitis/chol-
angitis or extrahepatic biliary ductal abnormalities on
radiographic images were identified.21 Septic metastatic
infection was defined as a distant site of infection with the
same pathogen (K. pneumoniae) as in the pyogenic liver
abscess. Definitive antibiotic therapy was defined as initial
and continuous administration of antibiotics after suscep-
tibility testing of cultures was available.27 If the patient
received various antibiotics after the culture results were
available, the antibiotic with the longest duration of
administration was considered as the definitive therapy.
According to the policy of the Department of Infection
Control in our hospital, amoxicillin-clavulanate, ampicillin-
sulbactam, and first- or second- generation cephalosporins
were defined as first-line antibiotics. Cephamycins, third-
or fourth-generation cephalosporins, fluoroquinolones,
tigecycline, piperacillin-tazobactam, colistin, and all car-
bapenems were defined as second-line antibiotics. The
prolonged hospitalization was defined as hospital stays
21 days. The prolonged stay in the general ward was
defined as being hospitalized in the general ward 21
days.
Cost data analysis
The total hospitalization expenditure of each episode of
KPLA was assessed from the hospital’s perspective as
Table 1 Clinical characteristics and economic conse-
quence of 104 patients with Klebsiella pneumoniae liver
abscess in Taiwan.
Characteristics No. (%)
Male 72 (69.2)
Age, y 63.7  15.9
Underlying disease
Diabetes mellitus 51 (49.0)
Malignancy 13 (12.5)
Alcoholism 7 (6.7)
Chronic kidney diseasea 5 (4.8)
Liver cirrhosis 4 (3.8)
Congestive heart failure 7 (6.7)
Chronic lung disease 5 (4.8)
Charlson Comorbidity Index 2.6  2.0
Origin of liver abscess
Cryptogenic 77 (74.0)
Biliary tract origin 27 (26.0)
Abscess location
Right lobe 78 (75.0)
Left lobe 11 (10.6)
Both lobes 15 (14.4)
Abscess size, cm
<5 46 (44.2)
5 58 (55.8)
Treatment
Antibiotics þ drainage 90 (86.5)
Antibiotics þ operation 4 (3.8)
Antibiotics only 10 (9.6)
Metastatic infections 5 (4.8)
APACHE II score 14.0  6.6
Length of hospital stay, d 25.0  15.2
Duration of antibiotic use, d 24.3  14.2
Requirement of intensive care
on admission
23 (22.1)
Mortality rate 3 (2.9)
Total hospitalization cost ($) 6337.5  4363.4
Average daily hospitalization cost ($) 280.9  281.1
a Baseline serum creatinine 2 mg/dL.
Data are presented as mean  standard deviation or frequency
with percentage (%).
APACHE Z Acute Physiology and Chronic Health Evaluation.
192 P.-F. Wu et al.described in a previous article.28 The average daily cost was
also analyzed. All costs, including accommodation, physi-
cian rounds, nursing care, pharmacy, medications, labora-
tory procedures and operations, other true costs per item
or service, and food, of each inpatient since admittance to
the emergency department until discharge from hospital
were included, and were extracted from the hospital
database. Fixed costs (e.g., costs of buildings, equipment,
and salaried labor) were not included. The costs were
converted to 2011 US dollars (1 Taiwan dollar Z 0.03 US
dollar) according to the Foreign Exchange Regime of the
Central Bank of the Republic of China (Taiwan).
Statistical analysis
Analysis of categorical data was performed by Chi-square
test or Fisher exact test. Numerical data were analyzed by
the two-tailed Student t test or Mann-Whitney U test. Two-
sided p < 0.05 were considered significant. To determine
the factors associated with high average daily and total
hospitalization expenditure for KPLA, a logistic regression
analysis was performed.
Results
Clinical characteristics and economic consequence
of KPLA
During the study period, a diagnosis was made in a total of
153 patients with microbiological evidence of pyogenic liver
abscess. The most common identified organism was K.
pneumoniae (70%), followed by E. coli (14.4%), and
Enterococcus species (4.6%). Finally, 107 patients in whom
KPLA was diagnosed were enrolled. Three patients were
excluded from the subsequent analysis because of distinct
characteristics and exceedingly high costs during the same
hospitalization. Two of these patients received targeted
therapy for malignancy after resolution of the liver ab-
scesses. The other patient developed a liver abscess after
transhepatic arterial chemoembolization for hepatocellular
carcinoma. Table 1 demonstrated the clinical characteris-
tics and economic consequence of the remaining 104 pa-
tients with KPLA during the study period. The mean length
of hospital stay was 25.0  15.2 days. The duration of
antibiotic use (mean, 24.3  14.2 days) was nearly the
same as length of hospital stay. All patients received anti-
biotics throughout nearly the whole hospitalization course
except for three patients staying in the hospital for an
additional 3 days after discontinuation of antibiotics. The
lowest estimated hospitalization cost was $1644.50, the
highest cost was $27,431.80, and the median cost was
$5290.80.
Potential predictive factors for the high total cost
of KPLA
To identify the independent risk factors for increased hos-
pitalization expenditure, we stratified the patients into
high cost and non-high cost groups using the median cost
($5246.30) as the cutoff point. Three patients who diedwere excluded from the analysis because of possible bias in
the cost of hospitalization. One of these patients died
within 24 hours after admission with very low cost of hos-
pitalization, and two died from terminal cancer. Logistic
regression analysis revealed that longer length of hospital
stay [odds ratio (OR) 1.44; 95% confidence interval (CI),
1.24e1.67; p < 0.001] was the only independent risk factor
for the high total cost of hospitalization (Table 2).
We further analyzed whether prolonged stay in the
general ward (21 days) contributed to the high total cost
of hospitalization. The variable “length of hospital stay”
was replaced by prolonged stay in the general ward in the
statistical analysis. Logistic regression analysis revealed
that prolonged stay in the general ward was as well the
independent predictor for the high total cost of hospitali-
zation (OR 39.94; 95% CI 10.40e153.40, p < 0.001).
Table 2 Analysis of potential risk factors for the high cost of hospitalization from Klebsiella pneumoniae liver abscess in a
tertiary care hospital in northern Taiwan.
Factor Non-high cost of
hospitalization
(n Z 50)
n (%)
High cost of
hospitalization
(n Z 51)
n (%)
Univariate Multivariate analysis
p Odds ratio (95% CI) p
Male 33 (66.0) 38 (74.5) 0.351 1.55 (0.33e7.25) 0.576
Age (y) 61.5  15.2 65.8  16.3 0.172 1.02 (0.98e1.07) 0.319
Charlson Comorbidity Index 2.4  2.0 2.5  1.6 0.887 d d
Underlying disease
Diabetes 24 (48.0) 24 (47.1) 0.925 d d
Malignancy 7 (14.0) 4 (7.8) 0.327 d d
Alcoholism 3 (6.0) 4 (7.8) 0.716 d d
Chronic kidney diseasea 2 (4.0) 3 (5.9) 0.665 d d
Liver cirrhosis 2 (4.0) 2 (3.9) 0.984 d d
Congestive heart failure 2 (4.0) 5 (9.8) 0.266 d d
Chronic lung disease 3 (6.0) 2 (3.9) 0.633 d d
Cryptogenic 38 (76.0) 38 (74.5) 0.862 d d
Abscess in both lobes 6 (12.0) 8 (15.7) 0.593 d d
Abscess size 5 cm 26 (52.0) 29 (56.9) 0.624 d d
Treatment
Antibiotics þ drainage 42 (84.0) 47 (92.2) 0.539 d d
Antibiotics þ operation 0 (0.0) 4 (7.8) d d d
Antibiotics only 6 (12.0) 2 (3.9) 0.152 d d
Definitive treatment with
2nd line antibiotics
34 (68.0) 38 (74.5) 0.470
Metastatic infections 0 (0.0) 4 (7.8) d d d
APACHE II score 15 14 (28.0) 30 (58.8) 0.002 5.00 (0.74-33.67) 0.098
Requirement of intensive
care on admission
5 (10.0) 17 (33.3) 0.007 2.79 (0.29e26.91) 0.374
Length of hospital stay, d 16.2  5.2 34.1  16.5 <0.001 1.44 (1.24e1.67) <0.001
Prolonged stay in the general ward 8 (16.0) 41 (80.4) <0.001 39.94 (10.40e153.40) <0.001
a Baseline serum creatinine 2 mg/dL.
Data are presented as mean  standard deviation or frequency with percentage (%).
APACHE Z Acute Physiology and Chronic Health Evaluation; CI Z confidence interval.
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hospitalization of KPLA
Table 3 showed the univariate analysis for the risk factors
for prolonged hospitalization (21 days). A higher APACHE II
score and the requirement of intensive care on admission
seem to predispose for prolonged hospitalization, but they
did not reach statistical significance in the logistic regres-
sion model. We further determined the risk factors for
prolonged stay in the general ward and did not find the risk
factors predisposing to prolonged stay in the general ward,
as shown in Table 4.Potential predictive factors for the high average
daily cost of KPLA
For identifying the independent risk factors for increased
hospitalization expenditure, the patients with KPLA were
stratified into high and non-high average daily cost groups
using the median average daily cost ($249.40) as the cutoff
point (Table 5). Logistic regression analysis revealed that ahigher Charlson Comorbidity Index (OR 1.49; 95% CI,
1.11e1.99; p Z 0.007) and the requirement of intensive
care on admission (OR 5.99; 95% CI, 1.65e21.71; pZ 0.006)
were the independent risk factors for the high average daily
cost of hospitalization.
Discussion
K. pneumoniae is the predominant pathogen of pyogenic
liver abscess in Taiwan, and is responsible for the endemic
nature of this disease.2 This study was the first to demon-
strate the clinical characteristics and the economic con-
sequences of KPLA in Taiwan in recent years. Our study
showed that the only independent risk factor for the high
total cost of hospitalization was the length of hospital stay.
The independent risk factors for the high average daily cost
of hospitalization were a higher Charlson Comorbidity Index
and the requirement of intensive care on admission.
Kang and Hwang29 have described the in-hospital costs
of all cases of pyogenic liver abscess in 2007 in Taiwan using
the National Health Insurance Research Database. Patients
aged 65 years or older had a significantly higher mean cost
Table 3 Analysis of risk factors for prolonged hospitalization of patients with Klebsiella pneumoniae liver abscess in a tertiary
care hospital in northern Taiwan.
Factor Length of hospitalization
<21 days (n Z 45)
n (%)
Length of hospitalization
21 days (n Z 56)
n (%)
p
Male 30 (66.7) 41 (73.2) 0.475
Age, y 62.1  15.2 65.0  16.4 0.371
Underlying disease
Diabetes mellitus 21 (46.7) 27 (48.2) 0.877
Malignancy 7 (15.6) 4 (7.1) 0.187
Alcoholism 3 (6.7) 4 (7.1) 0.925
Chronic kidney diseasea 3 (6.7) 2 (3.6) 0.483
Liver cirrhosis 2 (4.4) 2 (3.6) 0.823
Congestive heart failure 3 (6.7) 4 (7.1) 0.925
Chronic lung disease 3 (6.7) 2 (3.6) 0.483
Charlson Comorbidity Index 2.6  2.0 2.3  1.6 0.376
Origin of liver abscess
Cryptogenic 33 (73.3) 43 (76.8) 0.690
Biliary tract origin 12 (26.7) 13 (23.2)
Abscess location
Right lobe 34 (75.6) 43 (76.8) 0.932
Left lobe 5 (11.1) 5 (8.9)
Both lobes 6 (13.3) 8 (14.3)
Abscess size, cm
<5 23 (51.1) 23 (41.1) 0.315
5 22 (48.9) 33 (58.9)
Treatment
Antibiotics þ drainage 38 (84.4) 49 (87.5) 0.659
Antibiotics þ operation 0 (0) 4 (7.1)
Antibiotics only 7 (15.6) 3 (5.4) 0.102
Definitive antibiotic use
1st line antibiotics 16 (35.6) 13 (23.2) 0.176
2nd line antibiotics 29 (64.4) 43 (76.8)
Metastatic infections 0 (0) 4 (7.1)
APACHE II score 12.2  6.3 15.3  6.7 0.021
Requirement of intensive care on admission 6 (13.3) 16 (28.6) 0.071
a Baseline serum creatinine 2 mg/dL.
Data are presented as mean  standard deviation or frequency with percentage (%).
APACHE Z Acute Physiology and Chronic Health Evaluation.
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($3082.10  $3014.30 vs. $2594.70  $2457.90, p < 0.001).
However, the mean cost of patients with KPLA in our hos-
pital was $6337.50 during 2011e2012, which was markedly
higher than that determined from the 2007 nationwide
population-based data. We also did not find that age 65
years or older was associated with higher costs. The low
mortality resulting from improved diagnosis and manage-
ment of KPLA in recent years has undoubtedly led to the
increased healthcare expenditure for this disease. The high
healthcare expenditure of KPLA indicates that the eco-
nomic burden will be an important issue in the future. In
contrast to the previous study by Kang and Hwang29 of
pyogenic liver abscess, which did not include emergency
department expenditure, the cost estimated in our study
better reflects the overall economic burden of KPLA.
Another possible reason for the differences was the
different study population. Our hospital serves as a primarycare hospital and a tertiary referral medical center, and
hence patients might be slightly skewed to the severe side.
In addition, the mean hospital stays were 17.8  11.4 days
in patients aged 65 years and older and 16.5  10.1 in pa-
tients aged younger than 65 years in the nationwide
population-based study. The long mean duration of hospi-
talization in our study (25.0  15.2 days) likely contributes
to the higher cost of the disease in our study. Last, the
nationwide population-based study enrolled all liver ab-
scess cases, not limiting to KPLA as the current study, and
this may have contributed to the different results.
The only independent risk factor for the high total cost
of hospitalization in the current study was the length of
hospital stay. Previous research in Taiwan described vari-
able durations of hospital stay for KPLA. Tsai et al2 reported
a mean KPLA hospitalization of 26.1  16.4 days in a
medical center in northern Taiwan during 1996e2004. In a
medical center in central Taiwan, the mean hospital stay
Table 4 Analysis of risk factors for prolonged stay in the general ward of patients with Klebsiella pneumoniae liver abscess in
a tertiary care hospital in northern Taiwan.
Factor Length of hospitalization
in the general ward <21
days (n Z 52)
n (%)
Length of hospitalization
in the general ward 21
days (n Z 49)
n (%)
p
Male 36 (69.2) 35 (71.4) 0.809
Age, y 62.6  16.0 64.9  15.7 0.461
Underlying disease
Diabetes mellitus 25 (48.1) 23 (46.9) 0.909
Malignancy 7 (13.5) 4 (8.2) 0.397
Alcoholism 4 (7.7) 3 (6.1) 0.757
Chronic kidney diseasea 3 (5.8) 2 (4.1) 0.697
Liver cirrhosis 2 (3.8) 2 (4.1) 0.952
Congestive heart failure 3 (5.8) 4 (8.2) 0.637
Chronic lung disease 4 (7.7) 1 (2.0) 0.223
Charlson Comorbidity Index 2.5  2.0 2.4  1.6 0.670
Origin of liver abscess
Cryptogenic 38 (73.1) 38 (77.6) 0.603
Biliary tract origin 14 (26.9) 11 (22.4)
Abscess location
Right lobe 38 (73.1) 39 (79.6) 0.738
Left lobe 6 (11.5) 4 (8.2)
Both lobes 8 (15.4) 6 (12.2)
Abscess size, cm
<5 25 (48.1) 21 (42.9) 0.599
5 27 (51.9) 28 (57.1)
Treatment
Antibiotics þ drainage 47 (90.4) 42 (85.7) 0.471
Antibiotics þ operation 0 (0) 4 (8.2)
Antibiotics only 5 (9.6) 3 (6.1) 0.519
Definitive antibiotic use
1st line antibiotics 19 (36.5) 10 (20.4) 0.077
2nd line antibiotics 33 (63.5) 39 (79.6)
Metastatic infections 1 (1.9) 3 (6.1) 0.305
APACHE II score 12.9  6.3 15.0  6.9 0.103
Requirement of intensive care on admission 10 (19.2) 12 (24.5) 0.523
a Baseline serum creatinine 2 mg/dL.
Data are presented as mean  standard deviation.
APACHE Z Acute Physiology and Chronic Health Evaluation.
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in the study by Yang et al,6 and the median hospitalization
time was 19 days between July 2000 and June 2005 in the
study by Chen et al14 Chan et al13 reported a mean length of
stay of 17.4  8.7 days in a medical center in southern
Taiwan between January 2000 and June 2003, whereas Lee
et al9 reported a mean length of stay of 23.3  13.9 days in
another medical center in southern Taiwan during
2001e2002. Antibiotic treatment for pyogenic liver abscess
usually involves 2e3 weeks of parenteral administration
followed by oral antibiotics to complete a total course of
4e6 weeks.30,31 How to reduce the duration of hospitali-
zation is a challenge we face in the modern era of KPLA
management.
In Singapore, K. pneumoniae is also the most common
organism isolated from patients with pyogenic liver ab-
scess.10 In Singapore, Chan et al10 conducted a prospective
cohort study of all cases of KPLA treated from 2005 to 2011at two outpatient parenteral antimicrobial therapy (OPAT)
centers to assess the safety and efficacy of this treatment.
The mean length of hospital stay was 15  10 days, which
was lower than in previous studies in Taiwan.6,9,13,14 They
concluded that the management of KPLA via OPAT using a
standardized protocol is a safe and effective alternative to
inpatient intravenous antibiotics. In the current study, the
duration of antibiotic use was nearly the same as hospi-
talization days. We cannot exploit the length of stay in the
intensive care unit ward because of the high disease
severity. The prolonged stay in the general ward was the
independent risk factor for the high total cost. Therefore,
adoption of OPAT to reduce the length of stay may be one
of the ways to tackle the problem in Taiwan in the future.
The independent risk factors for a high average daily
cost of hospitalization in the current study were a higher
Charlson Comorbidity Index and the requirement of inten-
sive care on admission. KPLA is a notable community-
Table 5 Analysis of potential risk factors for the high average daily cost of hospitalization from Klebsiella pneumoniae liver
abscess in a tertiary care hospital in northern Taiwan.
Factor Non-high average daily
cost of hospitalization
n Z 50
n (%)
High average daily
cost of hospitalization
n Z 51
n (%)
Univariate analysis Multivariate analysis
p Odds ratio (95% CI) p
Male 36 (72.0) 35 (68.6) 0.711 1.05 (0.39e2.82) 0.917
Age, y 61.5  16.5 65.8  15.0 0.172 1.01 (0.98e1.04) 0.402
Charlson Comorbidity Index 1.9  1.5 3.0  1.9 0.004 1.49 (1.11e1.99) 0.007
Underlying disease
Diabetes 23 (46.0) 25 (49.0) 0.761
Malignancy 2 (4.0) 9 (17.6) 0.043
Alcoholism 5 (10.0) 2 (3.9) 0.245
Chronic kidney diseasea 1 (2.0) 4 (7.8) 0.209
Liver cirrhosis 3 (6.0) 1 (2.0) 0.322
Congestive heart failure 2 (4.0) 5 (9.8) 0.266
Chronic lung disease 2 (4.0) 3 (5.9) 0.665
Cryptogenic 38 (76.0) 38 (74.5) 0.862
Abscess in right hepatic lobes 36 (72.0) 41 (80.4) 0.324
Abscess size 5 cm 26 (52.0) 29 (56.9) 0.624
Treatment
Antibiotics þ drainage 42 (84.0) 47 (92.2) 0.214
Antibiotics þ operation 2 (4.0) 2 (3.9) 0.984
Antibiotics only 6 (12.0) 2 (3.9) 0.152
Definitive treatment with
2nd line antibiotics
33 (66.0) 39 (76.5) 0.247
Metastatic infections 2 (4.0) 2 (3.9) 0.984
APACHE II score 15 16 (32.0) 28 (54.9) 0.022 1.09 (0.41e2.96) 0.859
Length of hospital stay, d 25.7  15.4 24.8  15.1 0.781
Requirement of intensive
care on admission
5 (10.0) 17 (33.3) 0.007 5.99 (1.65e21.71) 0.006
a Baseline serum creatinine 2 mg/dL.
Data are presented as mean  standard deviation.
APACHE Z Acute Physiology and Chronic Health Evaluation; CI Z confidence interval.
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burden from KPLA due to the underlying comorbidities and
disease severity is an unavoidable problem in Taiwan. Lin
et al32 conducted a population-based, cross-sectional
study, using National Health Insurance administrative
claims data in Taiwan to study the cost of community-
acquired pneumonia during 2002e2004. The mean cost
per patient with pneumonia was $1957.00, which was
markedly lower than the mean cost per patient of KPLA of
$6337.50 in our study. In view of this high economic burden
and the increasing prevalence of KPLA in Taiwan, devel-
opment of a vaccine for prophylaxis of KPLA, especially in a
high-risk population, may be an important consideration for
the future.
There are some limitations to our retrospective study.
First, this was a hospital-based study. All data were
collected from medical records, and the study population
was restricted to patients from a tertiary medical center in
northern Taiwan. Second, the cost data were only available
in 2011 and 2012, and further longer follow-up is necessary
to better determine the economic burden of KPLA. Despite
these limitations, our study is believed to be the first to
determine the hospitalization cost of KPLA in Taiwan.
In conclusion, the current study for the first time
demonstrated the high economic burden of KPLA in ourhospital. The only independent risk factor for a high total
cost of hospitalization was the length of hospital stay. The
duration of antibiotic use was nearly the same as length of
hospital stay. The prolonged stay in the general ward (21
days) also contributed to the high total cost of hospitaliza-
tion. The economic burden of KPLA undoubtedly will be a
challenge in the future in Taiwan. Therefore, standardizing
the inpatient treatment protocol and introducing an outpa-
tient parenteral antimicrobial therapy center for KPLA pa-
tients to reduce the length of stay are necessary in Taiwan.
Development of a vaccine for high risk patients may also be
necessary to tackle endemic KPLA in the future.Conflicts of interest
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